Another group concluded that cisplatin uptake in human ovarian cancer cells (A2780) depends on the presence of the LRRC8A subunit and is sensitive to volume changes and that cisplatin resistance of these cells is associated with decreased LRRC8A expression. This evidence concerns the gene LRRC8A and ovarian cancer.